small molecule

GYNE-LOTRIMIN COMBINATION PACK

CLOTRIMAZOLE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameGYNE-LOTRIMIN COMBINATION PACK
Active ingredientCLOTRIMAZOLE
Strength1%,100MG
Dosage formCREAM, TABLET
RouteTOPICAL, VAGINAL
ModalitySmall molecule
FDA approvalApril 1993
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.